tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

BridgeBio Pharma: Buy Rating Reiterated as Acoramidis Data Strengthen Efficacy Profile and 12-Month Price Target Held at $120
RatingsBridgeBio Pharma: Buy Rating Reiterated as Acoramidis Data Strengthen Efficacy Profile and 12-Month Price Target Held at $120
22h ago
BBIO
BridgeBio Pharma files $500M mixed securities shelf
PremiumThe Fly
BridgeBio Pharma files $500M mixed securities shelf
1d ago
BBIO
BBOT
BridgeBio Pharma price target raised to $110 from $96 at Mizuho
PremiumThe Fly
BridgeBio Pharma price target raised to $110 from $96 at Mizuho
2d ago
BBIO
BridgeBio Pharma Expands Access to Rare Disease Therapies
PremiumCompany Announcements
BridgeBio Pharma Expands Access to Rare Disease Therapies
3d ago
8K
BBIO
BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study
PremiumThe Fly
BridgeBio Pharma presents new analyses from Phase 3 ATTRibute-CM study
4d ago
BBIO
BridgeBio Pharma doses first patient in ASCEND-ATTR trial
PremiumThe FlyBridgeBio Pharma doses first patient in ASCEND-ATTR trial
8d ago
BBIO
BridgeBio Pharma participates in a conference call with Cantor
Premium
The Fly
BridgeBio Pharma participates in a conference call with Cantor
10d ago
BBIO
BridgeBio Pharma Earnings Call Signals Growth Amid Risks
Premium
Company Announcements
BridgeBio Pharma Earnings Call Signals Growth Amid Risks
11d ago
BBIO
BridgeBio Pharma announces major secondary share offering
PremiumCompany Announcements
BridgeBio Pharma announces major secondary share offering
17d ago
8K
BBIO
BridgeBio price target raised to $94 from $93 at Citi
PremiumThe Fly
BridgeBio price target raised to $94 from $93 at Citi
17d ago
BBIO
BridgeBio price target raised to $106 from $104 at Canaccord
PremiumThe Fly
BridgeBio price target raised to $106 from $104 at Canaccord
17d ago
BBIO
BridgeBio price target raised to $111 from $100 at JPMorgan
PremiumThe Fly
BridgeBio price target raised to $111 from $100 at JPMorgan
17d ago
BBIO
BridgeBio price target raised to $107 from $102 at Truist
PremiumThe FlyBridgeBio price target raised to $107 from $102 at Truist
17d ago
BBIO
BridgeBio Oncology announces 5M common stock offering for holders
Premium
The Fly
BridgeBio Oncology announces 5M common stock offering for holders
18d ago
BBIO
BridgeBio 5M share Spot Secondary priced at $78.00
Premium
The Fly
BridgeBio 5M share Spot Secondary priced at $78.00
18d ago
BBIO
BridgeBio’s New Series A Preferred Stock Heightens Capital Structure Risk and Dilution Threat for Common Shareholders
PremiumCompany Announcements
BridgeBio’s New Series A Preferred Stock Heightens Capital Structure Risk and Dilution Threat for Common Shareholders
22d ago
BBIO
BridgeBio Earns Buy Rating on Attruby Outperformance and Multibillion-Dollar Growth Visibility
PremiumRatings
BridgeBio Earns Buy Rating on Attruby Outperformance and Multibillion-Dollar Growth Visibility
23d ago
BBIO
BridgeBio price target raised to $110 from $95 at TD Cowen
PremiumThe Fly
BridgeBio price target raised to $110 from $95 at TD Cowen
23d ago
BBIO
BridgeBio price target lowered to $97 from $98 at Morgan Stanley
PremiumThe Fly
BridgeBio price target lowered to $97 from $98 at Morgan Stanley
23d ago
BBIO
BridgeBio price target raised to $102 from $98 at Wells Fargo
PremiumThe FlyBridgeBio price target raised to $102 from $98 at Wells Fargo
23d ago
BBIO
BridgeBio price target raised to $115 from $111 at Piper Sandler
Premium
The Fly
BridgeBio price target raised to $115 from $111 at Piper Sandler
23d ago
BBIO
BridgeBio price target raised to $104 from $101 at BofA
Premium
The Fly
BridgeBio price target raised to $104 from $101 at BofA
23d ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >